The cause of the increase in core temperature (CT) during hemodialysis (HD) is still under debate. It has been suggested that peripheral vasoconstriction as a result of hypovolemia, leading to a reduced dissipation of heat from the skin, is the main cause of this increase in CT. If so, then it would be expected that extracorporeal heat flow (Jex) needed to maintain a stable CT (isothermic; T-control ‫؍‬ 0, no change in CT) is largely different between body temperature control HD combined with ultrafiltration (UF) and body temperature control HD without UF (isovolemic). Consequently, significant differences in ⌬CT would be expected between isovolemic HD and HD combined with UF at zero Jex (thermoneutral; E-control ‫؍‬ 0, no supply or removal of thermal energy to and from the extracorporeal circulation). During the latter treatment, the CT is expected to increase. In this study, changes in thermal variables (CT and Jex), skin blood flow, energy expenditure, and cytokines (TNF-␣, IL-1 receptor antagonist, and IL-6) were compared in 13 patients, each undergoing body temperature control (T-control ‫؍‬ 0) HD without and with UF and energy-neutral (E-control ‫؍‬ 0) HD without and with UF. CT increased equally during energy-neutral treatments, with (0.32 ؎ 0.16°C; P ‫؍‬ 0.000) and without (0.27 ؎ 0.29°C; P ‫؍‬ 0.006) UF. In body temperature control treatments, the relationship between Jex and UF tended to be significant (r ‫؍‬ ؊0.51; P ‫؍‬ 0.07); however, there was no significant difference in cooling requirements regardless of whether treatments were done without (؊17.9 ؎ 9.3W) or with UF (؊17.8 ؎ 13.27W). Changes in energy expenditure did not differ among the four treatment modes. There were no significant differences in pre-and postdialysis levels of cytokines within or between treatments. Although fluid removal has an effect on thermal variables, no single mechanism seems to be responsible for the increased heat accumulation during HD. A n inadequate vascular response to hypovolemia is an important contributory factor to intradialytic hypotension. Although various mechanisms have been implicated in the pathogenesis of impaired vascular response during hemodialysis (HD) (1-7), there are strong indications that this phenomenon is often related to changes in body temperature and extracorporeal blood temperature (8 -22).
A n inadequate vascular response to hypovolemia is an important contributory factor to intradialytic hypotension. Although various mechanisms have been implicated in the pathogenesis of impaired vascular response during hemodialysis (HD) (1) (2) (3) (4) (5) (6) (7) , there are strong indications that this phenomenon is often related to changes in body temperature and extracorporeal blood temperature (8 -22) .
We and others have observed that the core temperature (CT) increased during standard-temperature (37 to 38°C) dialysis (16,18 -24) even with net energy loss from the patient to the extracorporeal system. This phenomenon strongly suggests that the dialysis procedure itself leads to internal heat accumulation. It has been observed that 4 h of standard dialysis leads to a positive internal heat balance of approximately 300 kJ, which represents approximately 30% of the energy expenditure (EEvmax) of the patient (25) . The internal heat accumulation might very well be responsible for the impaired vascular response during HD, as the thermoregulatory response (leading to dilation of thermoregulatory vessels) will blunt the vascular response to hypovolemia. The cause of the increase in CT during dialysis is still under debate.
It has been hypothesized that as a consequence of ultrafiltration (UF)-induced hypovolemia, vasoconstriction occurs, which leads to reduced dissipation of heat from the body surface to the environment, leading to an increase in CT (26) . This hypothesis is further supported by the previously shown relation between UF volume and the removal of extracorporeal energy required to maintain a stable CT during body temperature control (isothermic) HD (27) . This hypothesis is in some contrast with other observations, using strain-gauge plethysmography, in which only a small increase in forearm vascular resistance was observed during HD combined with UF (8, 16, 22) . It therefore remains to be elucidated whether changes in peripheral vascular tone are solely responsible for the impressive heat accumulation observed during HD.
The thermal response to a decline in blood volume (BV) is best studied by comparing both changes in thermal variables and skin blood flow (SBF) between isovolemic HD, during which vasoreactivity is expected to be low if not abolished because UF is zero, and UF combined with HD. Comparing extracorporeal energy flow between isovolemic HD and UF combined with HD will enable the quantification of the heat stress of HD, which can be attributed to the vasoconstriction during a decline in BV. Studying heat accumulation during HD is best performed under body temperature control conditions, as changes in CT themselves may influence metabolic rate (28) . Moreover, comparing the metabolic rate between isovolemic HD and UF combined with HD will lead to a further understanding of the mechanism by which a decline in BV leads to an increase in heat stress.
The hypothesis of our study was that a reduction in heat loss by a reduction in SBF, as a result of peripheral vasoconstriction in response to a decline in BV, is the main cause of heat stress during HD combined with UF. Thus, the expectation was that significant differences in extracorporeal energy flow would be observed between body temperature control treatments with and without UF and that significant differences would be observed in the change of CT between energy-neutral treatments with and without UF. The aim of this study therefore was to compare the hemodynamic response and thermal factors between isovolemic HD and HD combined with UF under body temperature control (T-control ϭ 0, no change in CT) and energy-neutral (E-control ϭ 0, no supply or removal of thermal energy to and from the extracorporeal circulation) conditions.
Materials and Methods

Patients and Dialysis
Thirteen stable patients who were on chronic intermittent HD were studied. Exclusion criteria were frequent hypotensive episodes during HD, a central venous catheter as access for HD, and severe coronary heart disease or heart failure (New York Heart Association class 2 or more).
Patients gave informed consent to participate in this study, approved by the Beth Israel Medical Center Institutional Review Board (New York, NY). High-efficiency HD was delivered by volumetric machines (A2008H; Fresenius Medical Care, Walnut Creek, CA) and polysulfone dialyzers (F8 and F80; Fresenius Medical Care) using ultrapure bicarbonate dialysate (Diasafe; Fresenius Medical Care). Blood flow was 400 ml/min, and dialysate flow was 800 ml/min. Endotoxin activity in dialysate was Ͻ0.06 endotoxin units/ml (limulus amoebocyte lysate test; Associates of Cape Cod, Falmouth, MA). Dialyzers were used up to 15 times and disinfected for 20 h at 95°C with 1.5% citric acid.
With each patient serving as his or her own control, measurements during this observational study were performed under T-control conditions, i.e., patient temperature was controlled to remain constant (T-control ϭ 0), under extracorporeal E-control conditions, i.e., there was no supply or removal of thermal energy to and from the extracorporeal circulation (E-control ϭ 0), under isovolemic conditions when treatments were done without UF, and under regular UF conditions. Each patient was studied during four consecutive HD treatments, which differed in the type of treatment given; isovolemic HD under T-control conditions (T-control ϭ 0; HD:T-control ϭ 0), HD combined with UF under T-control conditions (T-control ϭ 0; HDϩUF:T-control ϭ 0), isovolemic HD under E-control conditions (E-control ϭ 0; HD:E-control ϭ 0), and HD combined with UF under E-control conditions (E-control ϭ 0; HDϩUF:E-control ϭ 0). Measurements were performed in randomized order. The sessions that were done under isovolemic conditions were followed by a phase that included UF so that at the end of the whole treatment, the patients would reach their target dry weight. Data were not collected during this phase.
Because the upright position may lead to heat accumulation, all measurements were done in the supine position. Furthermore, because eating and drinking affect thermogenesis, patients refrained from eating and drinking during the measurements (29) . Humidity in the room was approximately 60%.
Temperature Control
Arterial (T art ) and venous (T ven ) blood line temperatures as well as energy transfer between the extracorporeal circuit and the patient were monitored noninvasively at 15-s intervals using air-filled measuring heads with platinum temperature sensors (BTM; Fresenius Medical Care, Bad Homburg, Germany) fitted around the arterial and venous blood lines. Energy transfer was calculated by the formula c ϫ ϫ Qb ϫ (T art Ϫ T ven ) ϫ t, where c is specific thermal capacity (3.64 kJ/kg ϫ°C), Qb is the extracorporeal blood flow, is the density of blood (1052 kg/m 3 ), and t is the dialysis time in hours (30) .
Energy flow rate was set during HD:E-control ϭ 0 and HDϩUF:Econtrol ϭ 0 at 0 kJ/h, which means that no energy is fed to or withdrawn from the patient via the extracorporeal circuit. The automatic thermal energy balance control (E-mode) runs as follows: After the control function has been started, the BTM determines the T ven required to reach the thermal energy flow rate prescribed by the user. Then the dialysate temperature (T d ) is changed in such a way that the desired T ven is reached. In regular intervals, the BTM examines whether there is a deviation of the actual mean energy flow rate from the setting value. If this is the case, then the T d is adjusted to compensate for the deviation within a short period of time.
In the temperature-control mode (T-mode) provided by the BTM, arterial temperatures are monitored and dialysate temperatures are adjusted by a negative-feedback loop. During HD:T-control ϭ 0 and HDϩUF:T-control ϭ 0, the hourly change in patient temperature was set in the BTM at T-control ϭ 0.
The CT was measured by using the BTM described above. The BTM measures the temperature at the arterial side of the fistula and calculates central venous blood temperature by correcting for fistula and cardiopulmonary recirculation. This correction is necessary because arterial blood temperature is determined by the CT as well as by the temperature of any recirculating venous blood. In the BTM, recirculation is measured by a temperature bolus produced by a transient change in T d . Both the venous and the arterial line sensors of the BTM record the resulting change in blood temperatures. From the ratio in bolus amplitudes, recirculation can be calculated. Predialytic CT was defined as the first reliable temperature obtained (in all patients within 5 min) after the start of HD. The accuracy of the BTM temperature measurement is better than 0.05°C, and the reproducibility is better than 0.01°C as given by the manufacturer. It is also possible to read the instantaneous T d on the display of the BTM.
Blood Volume
Changes in BV were monitored continuously and noninvasively with the Fresenius BV monitor (BVM; Fresenius Medical Care), which measures changes in relative BV by measuring total protein concentration by ultrasonic means.
Skin Temperature
Skin temperature was measured by a Hewlett Packard device (HP 78204C; Boeblingen, Germany) with a monitoring range of 15 to 45°C, a resolution of 0.1°C, and an accuracy of 0.2°C (0.1°C instrument, 0.1°C temperature probe). Two attachable surface temperature probes (HP 21059A) were placed on the skin but not on a blood vessel of the contralateral arm of the vascular access. Measurements were done before and at the end of dialysis.
Skin Microcirculation
Skin microcirculation was studied by means of a Laser-Doppler device (Perimed KB0; Stockholm, Sweden) that measures noninvasively an integral of cutaneous blood flux in microvessels and shunts in the skin (31, 32) . The magnitude of cutaneous perfusion is given in arbitrary units (AU). The Laser-Doppler device was positioned at two places at the palmar side of the arm on the skin but not on a vessel. Measurements were done for 5 min before and at the end of dialysis. The arm was placed in supine position and did not move for the time of the measurement.
Energy Expenditure
Energy expenditure was obtained by indirect calorimetry (EEvmax). Concentrations of O 2 and CO 2 were measured continuously in exhaled air using a canopy covering the head of the patient and applying the mixing chamber technique procedure provided by a metabolic cart (Vmax29; SensorMedics Corp., Yorba Linda, CA) (33) . Measurements were done before and at the end of dialysis, and a measurement was successful when the patient reached a steady state and remained in this steady sate for at least 10 min. For obtaining values in watts (1 W ϭ 0.86 kcal/h), EEvmax recorded in kcal/d was divided by 20.64.
Cytokines
TNF-␣, IL-1 receptor antagonist (IL-1-ra), and IL-6 were measured before and at the end of dialysis by Enzyme-Linked Immunoassay (Cayman Reagents, Ann Arbor, MI).
Power Analysis
A power analysis using the data of van der Sande et al. (20) was performed with the 0-hypothesis-no change in CT during isovolemic energy-neutral HD (HD:E-control ϭ 0)-and the alternative hypothesis-increase in CT by 0.5°C (SD 0.4°C) during energy-neutral HD combined with UF (HDϩUF:E-control ϭ 0). For power 1 Ϫ ␤ ϭ 0.8 and ␣ ϭ 0.05, seven patients would be needed to detect significant differences with a paired design. A second power analysis using the data of Rosales et al. (27) with regard to T-control treatments was performed with the 0-hypothesis-no change in accumulated energy removal during isovolemic T-control HD (HD:T-control ϭ 0)-and the alternative hypothesis-change in accumulated energy removal of Ϫ186 kJ (SD 69 kJ) during T-control HD combined with UF (HDϩUF:T-control ϭ 0). For power 1 Ϫ ␤ ϭ 0.8 and ␣ ϭ 0.05, four patients would be needed to detect significant differences with a paired design.
Statistical Analyses
Accumulated energy removal and energy flow rate were compared under T-control conditions between HD:T-control ϭ 0 and HDϩUF:Tcontrol ϭ 0. CT was compared under thermal energy-neutral conditions between HD:E-control ϭ 0 and HDϩUF:E-control ϭ 0. All other parameters-room temperature, skin temperature (ST), skin microcirculation, EEvmax, and cytokines-were compared among all four treatment sessions. The comparisons of values within treatments and between different treatments were done by repeated measurements MANOVA (SPSS version 12.0.1; SPSS, Inc., Chicago, IL). P Ͻ 0.05 was considered to be significant. Data are expressed as mean Ϯ SD.
Results
Baseline Data
Baseline data at the start of dialysis are given in Table 1 . There were no significant differences in predialysis weight, room temperature, CT, SBF, and ST among the four different treatments.
Thermal Variables
CT remained stable during T-control sessions (Figure 1 ). Change in CT was 0.02 Ϯ 0.05°C during HD:T-control ϭ 0 (NS) and 0.04 Ϯ 0.13°C during HDϩUF:T-control ϭ 0 (NS).
CT increased significantly during energy-neutral sessions (Figure 1 ). Change in CT was 0.27 Ϯ 0.29°C during HD:Econtrol ϭ 0 (P ϭ 0.006) and 0.32 Ϯ 0.16°C during HDϩUF:Econtrol ϭ 0 (P ϭ 0.000). The change in CT between the two energy-neutral sessions was NS. There were no significant differences between the time of shift (early morning or afternoon) and the change in CT.
Control of extracorporeal heat flow for energy-neutral HD caused very small and insignificant changes in thermal energy (Figure 2 ). Change in thermal energy was Ϫ7 Ϯ 7 kJ during HD:E-control ϭ 0 (NS) and Ϫ5 Ϯ 6 kJ during HDϩUF:Econtrol ϭ 0 (NS) and not significantly different between the two energy-neutral sessions. T-control sessions, however, led to a a HD:T-control ϭ 0, isovolemic hemodialysis under body temperature control conditions, i.e., no change in core temperature; HDϩUF:T-control ϭ 0, hemodialysis combined with ultrafiltration under body temperature control conditions; HD:Econtrol ϭ 0, isovolemic hemodialysis under energy-neutral conditions, i.e., no change in energy flow; HDϩUF:E-control ϭ 0, hemodialysis combined with ultrafiltration under energy-neutral conditions; UF, ultrafiltration; AU, arbitrary units. significant change in thermal energy in treatment modes done with HDϩUF:T-control ϭ 0 (Ϫ225 Ϯ 113 kJ; P ϭ 0.000) or without UF HD:T-control ϭ 0 (Ϫ204 Ϯ 92 kJ; P ϭ 0.000). The amount in thermal energy removed was not significantly different between the two T-control sessions. Moreover, there were no significant differences between the time of shift (early morning or afternoon) and the amount of thermal energy removed.
Although in one patient there was an increase in CT of 0.3°C during HDϩUF:T-control ϭ 0, the energy removal was Ϫ186 kJ, which does not seem to differ from the rest of the patients. Moreover, there was no relation between changes in CT and accumulated energy removal during HDϩUF:T-control ϭ 0 (r ϭ 0237; NS). UF volume was found to be significantly related to the extracorporeal energy flow rate required to maintain a stable CT during HDϩUF:T ϭ control ϭ 0 (Figure 3) . There was no relationship between change in BV and extracorporeal energy flow rate in any one of the four sessions.
Room temperature increased slightly but significantly during all four treatments (Table 2) . However, there were no significant differences in the changes of room temperature among the four treatments. No relations between changes in room temperature and other thermal variables were observed.
In a multiple regression analysis model that included as independent variables changes in cytokine levels, changes in ST, changes in blood flow, and UF rate, with, respectively ⌬CT (change in CT) and Jex (energy flow rate) as dependent parameters, no significance was observed in any one of the four treatments.
BV
As expected, the changes in BV were almost zero during the sessions without UF, during HD:T-control ϭ 0 the change in BV was 2.3% (3.5%), and during HD:E-control ϭ 0 was 2.8% (1.8%). The change in BV during HDϩUF:T-control ϭ 0 was Ϫ16.1% (6.7%) and during HDϩUF:E-control ϭ 0 was Ϫ11.3% (6.5%).
ST
ST remained stable during both isovolemic sessions (Table 3 ) both under energy-neutral and T-control conditions. ⌬ST was Ϫ0.09 Ϯ 0.87°C during HD:T-control ϭ 0 (NS) and 0.41 Ϯ 0.95°C during HD:E-control ϭ 0 (NS). The difference in ⌬ST between the two isovolemic sessions was NS.
During both UF sessions, ST changed significantly both during T-control and energy-neutral conditions. However, the de- Figure 1 . Changes in core temperature (CT). HD:T-control ϭ 0 is isovolemic hemodialysis (HD) under body temperature control (T-control), i.e., no change in CT. HDϩUF:T-control ϭ 0 is HD combined with ultrafiltration (UF) under T-control conditions. HD:E-control ϭ 0 is isovolemic HD under energy-neutral conditions, i.e., no change in energy flow. HDϩUF:E-control ϭ 0 is HD combined with UF under energy-neutral conditions. Boxes indicate 25 to 75% with median value; capped bars indicate the range of data. crease in ST was significantly (P ϭ 0.005) larger during the T-control compared with the energy-neutral treatment (Table  3) . ⌬ST was Ϫ0.88 Ϯ 0.91°C during HDϩUF:T-control ϭ 0 (P ϭ 0.005) and 0.50 Ϯ 0.71°C during HDϩUF:E-control ϭ 0 (P ϭ 0.026).
SBF
SBF remained stable during both T-control and energy-neutral isovolemic sessions (Table 3, Figure 4 ). The change in SBF (⌬SBF) was 0.05 Ϯ 0.31 AU during HD:T-control ϭ 0 (NS) and 0.56 Ϯ 1.29 AU during HD:E-control ϭ 0 (NS). The difference in ⌬SBF between the two isovolemic sessions was NS. The change in SBF during HDϩUF:T-control ϭ 0 was significant (Ϫ0.93 Ϯ 0.59 AU; P ϭ 0.000) but not during HDϩUF:E-control ϭ 0 (Ϫ0.46 Ϯ 0.87 AU; P ϭ 0.082). The difference in ⌬SBF between T-control and energy-neutral treatments with UF was significant (P ϭ 0.001). The change in SBF between HDϩUF:T-control ϭ 0 and HD:T-control ϭ 0 was significant (P ϭ 0.001), as was the difference in ⌬SBF between HDϩUF:E-control ϭ 0 and HD:E-control ϭ 0 (P ϭ 0.011). In any one of the treatments, patients did not need to increase their SBF because of the increase, although small, in room temperature. There was also no relation in any one of the four treatments between SBF as dependent variable and ST and CT as independent variables. With Pearson analysis, there was a significant positive relation (r ϭ 0.587, P ϭ 0.035) between change in BV and change in SBF during HDϩUF:E-control ϭ 0. There was no relation between change in BV and change in SBF during HDϩUF:T-control ϭ 0.
Energy Expenditure
EEvmax remained stable during both T-control sessions (Table 4). The change in EEvmax (⌬EEvmax) was Ϫ4.01 Ϯ 7.62 W during HD:T-control ϭ 0 (NS) and Ϫ0.42 Ϯ 5.17 W during HDϩUF:T-control ϭ 0 (NS). The difference in ⌬EEvmax between the two T-control sessions was NS. EEvmax remained stable during HD:E-control ϭ 0 (Ϫ0.34 Ϯ 7.41 W; NS) and decreased significantly during HDϩUF:E-control ϭ 0 (Ϫ2.97 Ϯ 4.49 W; P ϭ 0.034). The difference in ⌬EEvmax between both energy-neutral sessions was NS, as was any combination between T-control and energy-neutral sessions. There were no significant differences between the time of shift (early morning or afternoon) and the change in EEvmax in any one of the sessions.
When EEvmax was calculated per body surface area, the same results as for EEvmax were observed (Table 4) . Respiratory quotient showed no change at all (Table 4) . 
Cytokines
There were no significant changes in TNF-␣, IL-1-ra, and IL-6 levels measured before and after dialysis in any one of the four sessions (Table 5 ). There were also no significant differences in changes in these cytokines between the sessions. Also, there was no correlation between changes in cytokines and CT and extracorporeal energy flow rate.
Discussion
The primary hypothesis of this study was that large thermal differences would be present between dialysis treatments with or without UF. In contrast to expectations, no significant difference in cooling requirements was observed when T-control (isothermic) treatments were done with or without UF (i.e., the same cooling to keep the CT constant). Furthermore, under energy-neutral (thermoneutral) conditions, there was a significant increase in CT, irrespective of whether patients received UF or not.
Previous data suggested that UF-induced vasoconstriction would result in a reduction of surface blood flow, a decrease in surface heat loss, and finally an increase in CT. As a consequence of the increase in CT, the blood flow to cutaneous vascular beds is increased at a later stage of the dialysis treatment, thus antagonizing the normal vascular response to hypovolemia (26) .
Indeed, SBF decreased during HD combined with UF and remained unchanged during the isovolemic treatments. Moreover, the decline in SBF during UF was significantly larger during T-control HD (during which CT is stable) compared with energy-neutral HD (during which CT increased), which is in agreement with the antagonistic effect of BP control mechanisms and thermoregulatory mechanisms acting on the same vascular bed (34) . ST also decreased during T-control treatment with UF and did not change during T-control treatment without UF. In line with the studies of Rosales et al. (27, 35) , a positive relationship between UF volume and energy flow rate was observed during T-control treatment. Still, the equal changes in CT between energy-neutral treatments and the absence of differences in extracorporeal energy flow rate during T-control treatments with and without UF are in contrast with the above-mentioned hypothesis and suggest that factors other than reduced heat loss by peripheral vasoconstriction are involved in heat accumulation during dialysis.
Especially changes in ST and SBF would be expected to be of importance in potential differences in thermal parameters (CT and energy flow rate) between treatments with and without UF, because of a reduced heat dissipation from the skin. In this study, it was shown that SBF and ST decreased during HDϩUF:T-control ϭ 0 in contrast to HD:T-control ϭ 0. That despite this finding no differences in energy flow rate and accumulated energy removal were observed points to the importance of other, yet-undefined factors in the pathogenesis of thermal changes during HD.
Apart from reduced heat loss, an increased metabolic rate during dialysis might lead to heat accumulation (25) . In our study, changes in EEvmax were not significantly different during the four treatment sessions, suggesting that changes in metabolic rate were neither the cause or the consequence of the increase in CT during HD under energy-neutral conditions nor the cause or the consequence of increased heat removal under T-control conditions. Our results are discrepant with those of Ikizler et al. (25) . However, the results of the latter study are difficult to interpret without information on CT, dialysate temperature, and purity of water (endotoxin level) for the preparation of dialysate. A reduced heat loss from the skin might also be due to environmental factors. During the treatments, room temperature increased by approximately 0.5°C. However, it seems unlikely that a change in environmental temperature will lead to a change in CT of the same magnitude. Moreover, changes in room temperature were equal among the four different treatments and were not related to any other thermal a ⌬IL-1-ra, change in IL-1 receptor antagonist; ⌬IL-6, change in IL-6; ⌬TNF-␣, change in TNF-␣.
variables. Since the publication of the "IL hypothesis," the effects of uremia and HD on the production of especially IL-1, TNF, and IL-6 by peripheral mononuclear cells have been studied extensively (36) . An increase in cytokine generation might increase CT by stimulation of the anterior hypothalamic area (37) . However, in this study, pre-and postdialysis values of TNF-␣, IL-1-ra, and IL-6 did not change during the different sessions and were not related to thermal variables. From a theoretical point of view, backfiltration of contaminated dialysate could play a causative role in the pathogenesis of thermal changes during HD. In this study, f80 and f8 dialyzers were used. However, as also shown by the negative microbiological cultures of the dialysate and limulus amoebocyte lysate tests, ultrapure dialysate (achieved by filtration of the dialysate through a Diasafe membrane [Fresenius Medical Care]) was used. Thus, it seems unlikely that backfiltration played a role in the thermal changes observed in this study.
Thus, although fluid removal has an effect on thermal variables, we could not confirm that hypovolemia by a reduction in SBF is the single cause of the increase in CT during HD. Moreover, metabolic rate and changes in cytokine levels did not seem to be responsible. Other factors, such as a removal of factors that decrease CT such as adrenomedullin during dialysis, or a circadian rhythm of CT deserve consideration (38) . Nevertheless, although the number of patients included in the study is too small for definite conclusions, no difference in thermal variables was observed between patients who were studied during morning and afternoon sessions. Moreover, metabolic rate, which is believed to be a driving force for circadian changes in CT (39), did not change during the study.
In conclusion, although fluid removal has an effect on thermal variables, no single mechanism seems to be responsible for the increased heat accumulation during HD.
